The effect of palm tocotrienol on surface osteoblast and osteoclast in excess glucocorticoid osteoporotic rat model

Mohamad Fairuz Yahaya, Azizi Zainodin, Reinukaa Pupathy, Edwin Ong Hock Min, Nurul Husna Abu Bakar, Nor Azimah Zamri, Halim Ismail, Elvy Suhana Mohd Ramli

Research output: Contribution to journalArticle

Abstract

A balanced interaction between osteoblast and osteoclast plays a major role in maintaining bone strength and structural integrity. Tocotrienol, a palm derivative with potent antioxidant properties showed an anti-osteoporotic effect but little is known about its mechanism of action. Hence, this research was conducted to determine the effects of palm tocotrienol on the surface osteoblast and osteoclast of the the glucocorticoid-induced osteoporotic bones. The study involved 40 male Sprague-Dawley rats weighing 250-300 g which were randomly divided into an equal number of Baseline, Sham, Adrx+Dexa (adrenalectomized with dexamethasone), Adrx+Dexa+ATF (adrenalectomized with dexamethasone supplemented with α-tocopherol) and Adrx+Dexa+PTT (adrenalectomized with dexamethasone supplemented with palm tocotrienol). Bloods were taken prior to sacrifice for serum biomarkers and either tibia or femur was harvested for bone biomarkers, gene expressions analysis and histological studies. A double-blinded experiment was performed to calculate the number of total cells (osteoblasts and osteoclast) with intact nuclei within five fields of view. While serum osteocalcin and gene expression did not show any changes, CTX level was increased in the Adrx+Dexa group but reduced after the supplementation of palm tocotrienol. Supplementation of palm tocotrienol also significantly decrease the osteoclast population (p<0.05) compared to Adrx+Dexa group. In contrast, osteoblast population showed no significant difference across the groups. The result showed that palm tocotrienol acts by modulating the osteoclasts but not osteoblast, which revert the dynamics of bone cells population in the osteoporotic bone to its pre-osteoporotic levels. Supplements of tocotrienol in daily diet may be beneficial in preventing osteoporosis.

Original languageEnglish
Pages (from-to)2731-2739
Number of pages9
JournalSains Malaysiana
Volume47
Issue number11
DOIs
Publication statusPublished - 1 Nov 2018

Fingerprint

Tocotrienols
Osteoclasts
Osteoblasts
Glucocorticoids
Bone and Bones
Dexamethasone
Biomarkers
Gene Expression
Tocopherols
Osteocalcin
Population Dynamics
Serum
Tibia
Femur
Population
Osteoporosis
Sprague Dawley Rats
Cell Count
Antioxidants
Diet

Keywords

  • Antioxidant
  • Osteoblast
  • Osteoclast
  • Osteoporosis
  • Vitamin E

ASJC Scopus subject areas

  • General

Cite this

The effect of palm tocotrienol on surface osteoblast and osteoclast in excess glucocorticoid osteoporotic rat model. / Yahaya, Mohamad Fairuz; Zainodin, Azizi; Pupathy, Reinukaa; Min, Edwin Ong Hock; Bakar, Nurul Husna Abu; Zamri, Nor Azimah; Ismail, Halim; Mohd Ramli, Elvy Suhana.

In: Sains Malaysiana, Vol. 47, No. 11, 01.11.2018, p. 2731-2739.

Research output: Contribution to journalArticle

Yahaya, Mohamad Fairuz ; Zainodin, Azizi ; Pupathy, Reinukaa ; Min, Edwin Ong Hock ; Bakar, Nurul Husna Abu ; Zamri, Nor Azimah ; Ismail, Halim ; Mohd Ramli, Elvy Suhana. / The effect of palm tocotrienol on surface osteoblast and osteoclast in excess glucocorticoid osteoporotic rat model. In: Sains Malaysiana. 2018 ; Vol. 47, No. 11. pp. 2731-2739.
@article{4e8c66182a744a4c8df4f5f610070efd,
title = "The effect of palm tocotrienol on surface osteoblast and osteoclast in excess glucocorticoid osteoporotic rat model",
abstract = "A balanced interaction between osteoblast and osteoclast plays a major role in maintaining bone strength and structural integrity. Tocotrienol, a palm derivative with potent antioxidant properties showed an anti-osteoporotic effect but little is known about its mechanism of action. Hence, this research was conducted to determine the effects of palm tocotrienol on the surface osteoblast and osteoclast of the the glucocorticoid-induced osteoporotic bones. The study involved 40 male Sprague-Dawley rats weighing 250-300 g which were randomly divided into an equal number of Baseline, Sham, Adrx+Dexa (adrenalectomized with dexamethasone), Adrx+Dexa+ATF (adrenalectomized with dexamethasone supplemented with α-tocopherol) and Adrx+Dexa+PTT (adrenalectomized with dexamethasone supplemented with palm tocotrienol). Bloods were taken prior to sacrifice for serum biomarkers and either tibia or femur was harvested for bone biomarkers, gene expressions analysis and histological studies. A double-blinded experiment was performed to calculate the number of total cells (osteoblasts and osteoclast) with intact nuclei within five fields of view. While serum osteocalcin and gene expression did not show any changes, CTX level was increased in the Adrx+Dexa group but reduced after the supplementation of palm tocotrienol. Supplementation of palm tocotrienol also significantly decrease the osteoclast population (p<0.05) compared to Adrx+Dexa group. In contrast, osteoblast population showed no significant difference across the groups. The result showed that palm tocotrienol acts by modulating the osteoclasts but not osteoblast, which revert the dynamics of bone cells population in the osteoporotic bone to its pre-osteoporotic levels. Supplements of tocotrienol in daily diet may be beneficial in preventing osteoporosis.",
keywords = "Antioxidant, Osteoblast, Osteoclast, Osteoporosis, Vitamin E",
author = "Yahaya, {Mohamad Fairuz} and Azizi Zainodin and Reinukaa Pupathy and Min, {Edwin Ong Hock} and Bakar, {Nurul Husna Abu} and Zamri, {Nor Azimah} and Halim Ismail and {Mohd Ramli}, {Elvy Suhana}",
year = "2018",
month = "11",
day = "1",
doi = "10.17576/jsm-2018-4711-16",
language = "English",
volume = "47",
pages = "2731--2739",
journal = "Sains Malaysiana",
issn = "0126-6039",
publisher = "Penerbit Universiti Kebangsaan Malaysia",
number = "11",

}

TY - JOUR

T1 - The effect of palm tocotrienol on surface osteoblast and osteoclast in excess glucocorticoid osteoporotic rat model

AU - Yahaya, Mohamad Fairuz

AU - Zainodin, Azizi

AU - Pupathy, Reinukaa

AU - Min, Edwin Ong Hock

AU - Bakar, Nurul Husna Abu

AU - Zamri, Nor Azimah

AU - Ismail, Halim

AU - Mohd Ramli, Elvy Suhana

PY - 2018/11/1

Y1 - 2018/11/1

N2 - A balanced interaction between osteoblast and osteoclast plays a major role in maintaining bone strength and structural integrity. Tocotrienol, a palm derivative with potent antioxidant properties showed an anti-osteoporotic effect but little is known about its mechanism of action. Hence, this research was conducted to determine the effects of palm tocotrienol on the surface osteoblast and osteoclast of the the glucocorticoid-induced osteoporotic bones. The study involved 40 male Sprague-Dawley rats weighing 250-300 g which were randomly divided into an equal number of Baseline, Sham, Adrx+Dexa (adrenalectomized with dexamethasone), Adrx+Dexa+ATF (adrenalectomized with dexamethasone supplemented with α-tocopherol) and Adrx+Dexa+PTT (adrenalectomized with dexamethasone supplemented with palm tocotrienol). Bloods were taken prior to sacrifice for serum biomarkers and either tibia or femur was harvested for bone biomarkers, gene expressions analysis and histological studies. A double-blinded experiment was performed to calculate the number of total cells (osteoblasts and osteoclast) with intact nuclei within five fields of view. While serum osteocalcin and gene expression did not show any changes, CTX level was increased in the Adrx+Dexa group but reduced after the supplementation of palm tocotrienol. Supplementation of palm tocotrienol also significantly decrease the osteoclast population (p<0.05) compared to Adrx+Dexa group. In contrast, osteoblast population showed no significant difference across the groups. The result showed that palm tocotrienol acts by modulating the osteoclasts but not osteoblast, which revert the dynamics of bone cells population in the osteoporotic bone to its pre-osteoporotic levels. Supplements of tocotrienol in daily diet may be beneficial in preventing osteoporosis.

AB - A balanced interaction between osteoblast and osteoclast plays a major role in maintaining bone strength and structural integrity. Tocotrienol, a palm derivative with potent antioxidant properties showed an anti-osteoporotic effect but little is known about its mechanism of action. Hence, this research was conducted to determine the effects of palm tocotrienol on the surface osteoblast and osteoclast of the the glucocorticoid-induced osteoporotic bones. The study involved 40 male Sprague-Dawley rats weighing 250-300 g which were randomly divided into an equal number of Baseline, Sham, Adrx+Dexa (adrenalectomized with dexamethasone), Adrx+Dexa+ATF (adrenalectomized with dexamethasone supplemented with α-tocopherol) and Adrx+Dexa+PTT (adrenalectomized with dexamethasone supplemented with palm tocotrienol). Bloods were taken prior to sacrifice for serum biomarkers and either tibia or femur was harvested for bone biomarkers, gene expressions analysis and histological studies. A double-blinded experiment was performed to calculate the number of total cells (osteoblasts and osteoclast) with intact nuclei within five fields of view. While serum osteocalcin and gene expression did not show any changes, CTX level was increased in the Adrx+Dexa group but reduced after the supplementation of palm tocotrienol. Supplementation of palm tocotrienol also significantly decrease the osteoclast population (p<0.05) compared to Adrx+Dexa group. In contrast, osteoblast population showed no significant difference across the groups. The result showed that palm tocotrienol acts by modulating the osteoclasts but not osteoblast, which revert the dynamics of bone cells population in the osteoporotic bone to its pre-osteoporotic levels. Supplements of tocotrienol in daily diet may be beneficial in preventing osteoporosis.

KW - Antioxidant

KW - Osteoblast

KW - Osteoclast

KW - Osteoporosis

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=85059229981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059229981&partnerID=8YFLogxK

U2 - 10.17576/jsm-2018-4711-16

DO - 10.17576/jsm-2018-4711-16

M3 - Article

VL - 47

SP - 2731

EP - 2739

JO - Sains Malaysiana

JF - Sains Malaysiana

SN - 0126-6039

IS - 11

ER -